120 related articles for article (PubMed ID: 22093053)
1. Topical timolol for a refractory wound.
Tang JC; Dosal J; Kirsner RS
Dermatol Surg; 2012 Jan; 38(1):135-8. PubMed ID: 22093053
[No Abstract] [Full Text] [Related]
2. Topical timolol for recalcitrant wounds.
Braun LR; Lamel SA; Richmond NA; Kirsner RS
JAMA Dermatol; 2013 Dec; 149(12):1400-2. PubMed ID: 24172892
[No Abstract] [Full Text] [Related]
3. Clinical pearl: topical timolol for refractory hypergranulation.
Waldman RA; Lin G; Sloan B
Cutis; 2019 Aug; 104(2):118-119. PubMed ID: 31603955
[TBL] [Abstract][Full Text] [Related]
4. Topical timolol promotes healing of chronic leg ulcer.
Thomas B; Kurien JS; Jose T; Ulahannan SE; Varghese SA
J Vasc Surg Venous Lymphat Disord; 2017 Nov; 5(6):844-850. PubMed ID: 29037357
[TBL] [Abstract][Full Text] [Related]
5. Topical 0.5% timolol heals a recalcitrant irradiated surgical scalp wound.
Beroukhim K; Rotunda AM
Dermatol Surg; 2014 Aug; 40(8):924-6. PubMed ID: 25006852
[No Abstract] [Full Text] [Related]
6. Topical timolol for chronic wounds in patients with junctional epidermolysis bullosa.
Chiaverini C; Passeron T; Lacour JP
J Am Acad Dermatol; 2016 Dec; 75(6):e223-e224. PubMed ID: 27846969
[No Abstract] [Full Text] [Related]
7. Polymorphism of the beta-2 adrenoceptor and IOP lowering potency of topical timolol in healthy subjects.
Fuchsjager-Mayrl G; Markovic O; Losert D; Lucas T; Wachek V; Muller M; Schmetterer L
Mol Vis; 2005 Sep; 11():811-5. PubMed ID: 16205624
[TBL] [Abstract][Full Text] [Related]
8. Application of Topical Timolol After CO2 Laser Resurfacing Expedites Healing.
Joo JS; Isseroff RR
Dermatol Surg; 2021 Mar; 47(3):429-431. PubMed ID: 31876577
[No Abstract] [Full Text] [Related]
9. Serum lipid profile and timolol gel.
Khamar MB; Bhatt N; Patel K
J Indian Med Assoc; 2002 Oct; 100(10):620-1. PubMed ID: 12452518
[TBL] [Abstract][Full Text] [Related]
10. Time course of changes in ocular wavefront aberration after instillation of 0.5% timolol gel-forming solution.
Hiraoka T; Daito M; Okamoto F; Kiuchi T; Hirohara Y; Mihashi T; Oshika T
Br J Ophthalmol; 2010 Apr; 94(4):433-9. PubMed ID: 19843537
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of a chronic venous leg ulcer using a topical beta-blocker.
Lev-Tov H; Dahle S; Moss J; Isseroff RR
J Am Acad Dermatol; 2013 Oct; 69(4):e204-5. PubMed ID: 24034405
[No Abstract] [Full Text] [Related]
12. Topical timolol and lipid profile.
Manoher JM; Sharma AK; Sahai R
Indian J Ophthalmol; 1995 Jun; 43(2):73-4. PubMed ID: 8818314
[TBL] [Abstract][Full Text] [Related]
13. Topical timolol for a chronic ulcer--a case with its own control.
Manahan MN; Peters P; Scuderi S; Surjana D; Beardmore GL
Med J Aust; 2014 Jan; 200(1):49-50. PubMed ID: 24438420
[No Abstract] [Full Text] [Related]
14. Peyronie's disease following long-term use of topical timolol.
Ross JJ; Rahman I; Walters RF
Eye (Lond); 2006 Aug; 20(8):974-6. PubMed ID: 16151480
[No Abstract] [Full Text] [Related]
15. Topical timolol for periocular hemangioma: report of further study.
Ni N; Langer P; Wagner R; Guo S
Arch Ophthalmol; 2011 Mar; 129(3):377-9. PubMed ID: 21403002
[No Abstract] [Full Text] [Related]
16. The role of topical timolol in wound healing and the treatment of vascular lesions: A narrative review.
Goodarzi A; Mozafarpoor S; Dodangeh M; Seirafianpour F; Shahverdi MH
Dermatol Ther; 2021 Mar; 34(2):e14847. PubMed ID: 33538017
[TBL] [Abstract][Full Text] [Related]
17. First report of topical timolol treatment in primarily ulcerated perineal haemangioma.
Cante V; Pham-Ledard A; Imbert E; Ezzedine K; Léauté-Labrèze C
Arch Dis Child Fetal Neonatal Ed; 2012 Mar; 97(2):F155-6. PubMed ID: 22190187
[No Abstract] [Full Text] [Related]
18. Evaluation of major depressive disorder in patients receiving chronic treatment with topical timolol.
Bali SJ; Parmar T; Arora V; Ichhpujani P; Sagar R; Dada T
Ophthalmologica; 2011; 226(3):157-60. PubMed ID: 21832816
[TBL] [Abstract][Full Text] [Related]
19. Prepared association of metipranolol 0.1% + pilocarpine 2% and of timolol 0.5% + pilocarpine 2%. Comparison of clinical efficacy and topical tolerability in the treatment of patients affected by POAG tonometrically uncontrolled with beta-blocker alone (two-centre study).
Boles Carenini B; Brogliatti B; Dorigo MT; Vadalà G; Protti R; Bellone A
Acta Ophthalmol Scand Suppl; 1997; (224):54-5. PubMed ID: 9589740
[No Abstract] [Full Text] [Related]
20. Topical timolol 0.5% gel-forming solution for small deep facial infantile hemangiomas.
Sorrell J; Chamlin SL
Pediatr Dermatol; 2013; 30(5):592-4. PubMed ID: 23889228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
